PEOPLE - Live Tissue Connect makes appointment:
This article was originally published in Clinica
Frank D'Amelio, former chief technology officer of Gyrus Group (visualisation and tissue management systems/instruments), has joined wound closure device manufacturer Live Tissue Connect, whose products are due to enter the European markets during the first quarter of the year. The firm is a subsidiary of CSMG Technologies (Corpus Christi, Texas), a technology management company that focuses on technologies developed in the Ukraine.
You may also be interested in...
A BLA filing for Zynteglo in beta-thalassemia is expected in the second half of 2020 instead of the first half, but the first commercial patient in the EU will be treated in the first half of this year.
Amid the ongoing spread of the coronavirus outbreak, China turns to novel and repurposed antiviral drugs but also courts traditional medicines to ease public fear over the largely unknown threat.
With Pataday Once Daily Relief (0.2% olopatadine) and Twice Daily (0.1%), Alcon adds allergy treatment to its lineup of OTC drops indicated for dry eye and redness. “Obviously, eye allergy will become a much bigger part of the portfolio for us,” says US vision care GM Sean Clark.